Evidence map›Paper›PMID 37433067›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2023

The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA-Associated Vasculitis.

Jessica L Bloom, Kaci Pickett-Nairn, Lori Silveira, Robert C Fuhlbrigge, David Cuthbertson, Praveen Akuthota, Thomas C Corbridge, Nader A Khalidi, Curry L Koening, Carol A Langford and 12 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Top ten tips in managing ANCA vasculitis.Clinical kidney journal · 2025
    Review
  15. Assessment of damage in Takayasu's arteritis.Rheumatology (Oxford, England) · 2025
    Observational
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 13 institutions in 2 countries.

Jessica L BloomUniversity of Colorado, Denver.ORCID 0000-0002-7645-2084
Kaci Pickett-NairnUniversity of Colorado, Denver.
Lori SilveiraUniversity of Colorado, Denver.
Robert C FuhlbriggeUniversity of Colorado, Denver.
David CuthbertsonUniversity of South Florida, Tampa.
Praveen AkuthotaUniversity of California San Diego, La Jolla.
Thomas C CorbridgeUS Medical Affairs-Respiratory GSK, Durham, North Carolina.
Nader A KhalidiSt. Joseph's Healthcare Hamilton, McMaster University, Ontario, Canada.
Curry L KoeningUniversity of Utah, Salt Lake City.
Carol A LangfordCleveland Clinic, Cleveland, Ohio.
Carol A McAlearUniversity of Pennsylvania, Philadelphia.
Paul A MonachBrigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0003-4937-0515
Larry W MorelandUniversity of Colorado, Denver.
Christian PagnouxMount Sinai Hospital, Toronto, Canada.
Rennie L RheeUniversity of Pennsylvania, Philadelphia.ORCID 0000-0002-4907-0304
Philip SeoJohns Hopkins University, Baltimore, Maryland.
Jared SilverUS Medical Affairs-Respiratory GSK, Durham, North Carolina.
Ulrich SpecksMayo Clinic, Rochester, Minnesota.
Kenneth J WarringtonMayo Clinic, Rochester, Minnesota.
Michael E WechslerNational Jewish Health, Denver, Colorado.
Peter A MerkelUniversity of Pennsylvania, Philadelphia.ORCID 0000-0001-9284-7345
Vasculitis Clinical Research Consortium
University of Colorado Denver · USUniversity of Pennsylvania · USDurham VA Medical Center · USMayo Clinic · USBrigham and Women's Hospital · USCleveland Clinic · USJohns Hopkins University · USMount Sinai Hospital · CANational Jewish Health · USSt. Joseph’s Healthcare Hamilton · CAUniversity of California San Diego · USUniversity of South Florida · USUniversity of Utah · US

Funding

VCRC-VF FellowshipU54AR057319 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MERKEL, PETER A · 2009 to 2020
$12.5M
VASCULITIS CLINICAL RESEARCH NETWORK (VCRN): RARE DISEASEU54RR019497 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MERKEL, PETER A · 2003 to 2008
$6.1M
NCATS NIH HHSNCRR NIH HHS U54 RR019497NCRR NIH HHS U54-RR-019497NIAMS NIH HHS U54 AR057319NIAMS NIH HHS U54-AR-057319
6 · The paper itself

Abstract

objectiveThis study examined the relationship between age at diagnosis and disease characteristics and damage in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

methodsAnalysis of a prospective longitudinal cohort of patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA) in the Vasculitis Clinical Research Consortium (2013-2021). Disease cohorts were divided by age at diagnosis (years): children (<18), young adults (18-40), middle-aged adults (41-65), and older adults (>65). Data included demographics, ANCA type, clinical characteristics, Vasculitis Damage Index (VDI) scores, ANCA Vasculitis Index of Damage (AVID) scores, and novel disease-specific and non-disease-specific damage scores built from VDI and AVID items.

resultsAnalysis included data from 1020 patients with GPA/MPA and 357 with EGPA. Female predominance in GPA/MPA decreased with age at diagnosis. AAV in childhood was more often GPA and proteinase 3-ANCA positive. Children with GPA/MPA experienced more subglottic stenosis and alveolar hemorrhage; children and young adults with EGPA experienced more alveolar hemorrhage, need for intubation, and gastrointestinal involvement. Older adults (GPA/MPA) had more neurologic manifestations. After adjusting for disease duration, medications, tobacco, and ANCA, all damage scores increased with age at diagnosis for GPA/MPA (P < 0.001) except the disease-specific damage score, which did not differ (P = 0.44). For EGPA, VDI scores increased with age at diagnosis (P < 0.009), whereas all other scores were not significantly different.

conclusionAge at diagnosis is associated with clinical characteristics in AAV. Although VDI and AVID scores increase with age at diagnosis, this is driven by non-disease-specific damage items.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisChurg-Strauss SyndromeGranulomatosis with PolyangiitisMicroscopic PolyangiitisAgedAntibodies, Antineutrophil CytoplasmicChildFemaleHemorrhageHumansMaleMiddle AgedProspective StudiesYoung AdultAntibodies, Antineutrophil Cytoplasmic

Identifiers

PMID37433067
PMCPMC10782596
OpenAlexW4383896119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.